The Johns Hopkins Congressional Briefing: What’s Next for Psychedelics

The Johns Hopkins Congressional BriefingПодробнее

Johns Hopkins Psychiatry Grand Rounds | Psychedelic Treatment LandscapeПодробнее

How psychedelics work, explained in under 6 minutes | Matthew JohnsonПодробнее

The Johns Hopkins 30-Minute COVID-19 Briefing: Dec. 11, 2020Подробнее

The Johns Hopkins Briefing: Prescription Drug ShortagesПодробнее

A Johns Hopkins Neuroscientist on Psychedelics and Mental HealthПодробнее

The “heroic dose” of psychedelics, according to Johns Hopkins | Dr. Matthew JohnsonПодробнее

Johns Hopkins Bloomberg School of Public Health Expert Media Briefing | January 24, 2024Подробнее

Johns Hopkins Psychiatry Grand Rounds – Neuropsychopharmacology of Psychedelic DrugsПодробнее

Johns Hopkins Coronavirus Resource Center Live 30-Minute Briefing - April 22, 2022Подробнее

Johns Hopkins Coronavirus Resource Center Live 30-Minute Briefing - Nov. 5, 2021Подробнее

Sickle Cell Disease Congressional BriefingПодробнее

Johns Hopkins Coronavirus Resource Center Live 30-Minute Briefing - Feb. 25, 2022Подробнее

Congressional Briefing on Kratom ScienceПодробнее

HopTalk: Psychedelics Research with Dr. Matt JohnsoПодробнее

Oprah Sits Down with the Founder of the Psychedelic Center at Johns Hopkins UniversityПодробнее

Psychedelic Treatment with Psilocybin Relieves Major DepressionПодробнее

Hopkins tests psychedelics to help quit smokingПодробнее